A COMPARATIVE STUDY BETWEEN INVESTIGATOR SAFETY DATA AND A PHARMACOVIGILANCE DATABASE:  A KEY ROLE OF THE PHARMACOVIGILANT IN THE RELEVANCY OF CLINICAL TRIAL PUBLICATIONS